First Time Loading...

Rigel Pharmaceuticals Inc
NASDAQ:RIGL

Watchlist Manager
Rigel Pharmaceuticals Inc Logo
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Watchlist
Price: 0.9825 USD 1.35% Market Closed
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

117.2m
+2%
Assets
Growth Rates:
1 Year
-13%
3 Years
+6%
5 Years
-16%
7 Years
+50%
10 Years
-48%
145.9m
-0.9%
Liabilities
Growth Rates:
1 Year
-1%
3 Years
+91%
5 Years
+400%
7 Years
+531%
10 Years
+719%
-28.6m
+10%
Equity
Growth Rates:
1 Year
-111%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Rigel Pharmaceuticals Inc

117.2m
Assets
145.9m
Liabilities
117.2m
Assets
145.9m
Liabilities
Current Assets 99.3m
Cash & Short-Term Investments 56.9m
Receivables 30.6m
Other Current Assets 11.8m
Non-Current Assets 18m
PP&E 1m
Intangibles 13.9m
Other Non-Current Assets 3.1m
Current Liabilities 53.3m
Accounts Payable 7.1m
Accrued Liabilities 18.2m
Other Current Liabilities 27.9m
Non-Current Liabilities 92.6m
Long-Term Debt 52.4m
Other Non-Current Liabilities 40.2m

Balance Sheet
Rigel Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
15
44
18
38
76
23
30
19
25
33
Cash Equivalents
15
44
18
38
76
23
30
19
25
33
Short-Term Investments
128
83
57
78
52
76
27
106
34
24
Total Receivables
6
0
0
0
4
10
16
16
40
31
Accounts Receivables
6
0
0
0
4
10
16
16
40
31
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
1
1
2
7
9
6
Other Current Assets
2
3
1
2
4
10
14
7
8
6
Total Current Assets
151
129
76
117
137
119
89
155
116
99
PP&E Net
3
2
1
1
1
28
21
12
3
1
PP&E Gross
3
2
1
1
1
28
21
12
3
1
Accumulated Depreciation
23
18
19
12
13
13
14
15
11
2
Intangible Assets
0
0
0
0
0
0
0
0
15
14
Other Long-Term Assets
1
1
1
1
1
1
1
1
1
3
Total Assets
154
N/A
132
-15%
78
-41%
119
+52%
139
+17%
148
+6%
110
-25%
167
+52%
134
-20%
117
-13%
Liabilities
Accounts Payable
2
3
6
3
6
4
4
4
23
7
Accrued Liabilities
7
12
11
15
20
29
34
44
24
18
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
7
Other Current Liabilities
5
19
6
0
1
25
3
16
19
21
Total Current Liabilities
14
34
23
18
28
58
41
64
65
53
Long-Term Debt
0
0
0
0
0
10
20
20
39
52
Other Liabilities
12
7
1
0
2
26
16
54
43
40
Total Liabilities
26
N/A
40
+56%
23
-43%
19
-20%
29
+58%
94
+221%
76
-19%
137
+79%
148
+8%
146
-1%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
940
992
1 061
1 139
1 209
1 276
1 306
1 324
1 383
1 408
Additional Paid In Capital
1 068
1 083
1 116
1 239
1 319
1 330
1 340
1 354
1 369
1 379
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
128
N/A
91
-29%
55
-40%
101
+83%
110
+9%
54
-51%
34
-37%
30
-11%
14
N/A
29
-111%
Total Liabilities & Equity
154
N/A
132
-15%
78
-41%
119
+52%
139
+17%
148
+6%
110
-25%
167
+52%
134
-20%
117
-13%
Shares Outstanding
Common Shares Outstanding
88
91
99
147
167
168
169
172
173
175

See Also

Summary
RIGL intrinsic value, competitors valuation, and company profile.
DCF Valuation
RIGL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RIGL stock valuation using valuation multiples.
Wall Street Estimates
RIGL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RIGL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.